Smoking cessation treatment among office-based buprenorphine treatment patients

Shadi Nahvi, Oni Blackstock, Nancy L. Sohler, Devin Thompson, Chinazo O. Cunningham

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9. years; most were men (74.2%) and Hispanic (70.9%). At buprenorphine initiation, 21.9% had no documentation of smoking status, while 67.4% were current, 10% former, and 0.9% never smokers. Of current smokers, 16.8% received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3% vs. 11.2%, p. <. 0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.

Original languageEnglish (US)
Pages (from-to)175-179
Number of pages5
JournalJournal of Substance Abuse Treatment
Volume47
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Buprenorphine
Withholding Treatment
Smoking Cessation
Prescriptions
Tobacco Use
Opioid Analgesics
Therapeutics
Smoking
Tobacco Use Cessation
Hispanic Americans
Smoke
Documentation

Keywords

  • Buprenorphine
  • Office-based treatment
  • Opioid
  • Smoking cessation
  • Tobacco smoking

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Phychiatric Mental Health
  • Medicine (miscellaneous)

Cite this

Smoking cessation treatment among office-based buprenorphine treatment patients. / Nahvi, Shadi; Blackstock, Oni; Sohler, Nancy L.; Thompson, Devin; Cunningham, Chinazo O.

In: Journal of Substance Abuse Treatment, Vol. 47, No. 2, 2014, p. 175-179.

Research output: Contribution to journalArticle

@article{cdeb3a364b8145deaf968f2f8257cb0e,
title = "Smoking cessation treatment among office-based buprenorphine treatment patients",
abstract = "Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9. years; most were men (74.2{\%}) and Hispanic (70.9{\%}). At buprenorphine initiation, 21.9{\%} had no documentation of smoking status, while 67.4{\%} were current, 10{\%} former, and 0.9{\%} never smokers. Of current smokers, 16.8{\%} received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3{\%} vs. 11.2{\%}, p. <. 0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.",
keywords = "Buprenorphine, Office-based treatment, Opioid, Smoking cessation, Tobacco smoking",
author = "Shadi Nahvi and Oni Blackstock and Sohler, {Nancy L.} and Devin Thompson and Cunningham, {Chinazo O.}",
year = "2014",
doi = "10.1016/j.jsat.2014.04.001",
language = "English (US)",
volume = "47",
pages = "175--179",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Smoking cessation treatment among office-based buprenorphine treatment patients

AU - Nahvi, Shadi

AU - Blackstock, Oni

AU - Sohler, Nancy L.

AU - Thompson, Devin

AU - Cunningham, Chinazo O.

PY - 2014

Y1 - 2014

N2 - Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9. years; most were men (74.2%) and Hispanic (70.9%). At buprenorphine initiation, 21.9% had no documentation of smoking status, while 67.4% were current, 10% former, and 0.9% never smokers. Of current smokers, 16.8% received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3% vs. 11.2%, p. <. 0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.

AB - Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9. years; most were men (74.2%) and Hispanic (70.9%). At buprenorphine initiation, 21.9% had no documentation of smoking status, while 67.4% were current, 10% former, and 0.9% never smokers. Of current smokers, 16.8% received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3% vs. 11.2%, p. <. 0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.

KW - Buprenorphine

KW - Office-based treatment

KW - Opioid

KW - Smoking cessation

KW - Tobacco smoking

UR - http://www.scopus.com/inward/record.url?scp=84903151258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903151258&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2014.04.001

DO - 10.1016/j.jsat.2014.04.001

M3 - Article

C2 - 24912863

AN - SCOPUS:84903151258

VL - 47

SP - 175

EP - 179

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 2

ER -